Post-Traumatic Stress Disorder (PTSD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

 Exposure to a traumatic event that threatens one's physical or psychological well-being can lead to Post-traumatic stress disorder (PTSD), a potential psychopathological outcome. People with PTSD often have recurring memories, sensations, and emotions related to the traumatic event, which can manifest as sensory flashbacks or nightmares. They may also exhibit avoidance behavior, difficulty concentrating, hypervigilance, sleep disturbances, irritability, and emotional withdrawal. Additionally, PTSD is linked to an increased risk of suicide, suicidal thoughts, and negative clinical consequences such as persistent post-traumatic headaches and disruptions in sensory processing. Diagnosing PTSD can be challenging due to misidentification and underreporting, complicating efforts to determine its prevalence. Stigma and limited access to healthcare can further hinder the accurate diagnosis of PTSD.

·       The PTSD prevalence ranged from 8.0% to 56.7%, the 1-year prevalence from 2.3% to 9.1%, and the lifetime prevalence from 3.4% to 26.9%.

 

Thelansis’s “Post-Traumatic Stress Disorder (PTSD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Post-Traumatic Stress Disorder (PTSD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Post-Traumatic Stress Disorder (PTSD) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Post-Traumatic Stress Disorder (PTSD) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Post-Traumatic Stress Disorder (PTSD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Post-Traumatic Stress Disorder (PTSD), Post-Traumatic Stress Disorder (PTSD) market outlook, Post-Traumatic Stress Disorder (PTSD) competitive landscape, Post-Traumatic Stress Disorder (PTSD) market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)